Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

4.35USD
22 Feb 2019
Change (% chg)

$-0.28 (-6.05%)
Prev Close
$4.63
Open
$4.66
Day's High
$4.87
Day's Low
$4.25
Volume
165,972
Avg. Vol
88,925
52-wk High
$17.39
52-wk Low
$3.25

Select another date:

Wed, Jan 30 2019

UPDATE 4-Roche, AC Immune drop Alzheimer drug trials after setback

* AC Immune shares plunge 65 percent (Adds AC Immune CEO commment, shares)

Lilly partners with AC Immune for Alzheimer's treatment

U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

UPDATE 1-Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 Eli Lilly & Co and AC Immune SA have agreed to jointly develop a potential treatment for Alzheimer's disease.

BRIEF-AC Immune Says Co's Selling Shareholder May Sell Up To 18 Mln Common Shares

* AC IMMUNE SAYS CO'S SELLING SHAREHOLDER MAY SELL UP TO 18 MILLION COMMON SHARES Source text: (https://bit.ly/2P0dXMm) Further company coverage:

Select another date: